A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma
Clinical trial NCT06084884 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06084884
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-14
- Primary completion
- 2027-12-13
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.